Mr. Todd Shapiro reports
RED LIGHT HOLLAND FURTHERS COLLABORATION WITH CCREST LABORATORIES TO DEVELOP HOMOGENIZED MICRODOSING CAPSULES AIMED AT EMERGING LEGAL MARKETS, UTILIZING A FOURTH HEALTH CANADA APPROVED PSILOCYBIN IMPORT PERMIT AND NEW AUTHORIZATION FOR ASSEMBLY
Three thousand grams (three kilograms) of Red Light Holland Corp.'s natural psilocybin truffles grown in the Netherlands have been approved by Health Canada to import to Red Light's partner, cGMP (current good manufacturing practice) licensed CCrest Laboratories in Montreal, Canada, for the purposes of product development of homogenized powder for microdosing capsules. CCrest Laboratories, which holds a Controlled Drugs & Substances Dealer's License, has announced plans to use its newly amended license, recently approved by Health Canada to include assembly and packaging, to develop homogenized microdosing capsules in partnership with Red Light Holland. These capsules will contain 0.5 mg of psychoactive material, a combination of psilocybin and psilocin, and will be packaged in child-proof safety bottles containing 20 capsules. This dosage and packaging were determined based on prior testing, as well as information obtained through the use of Red Light Holland's iMicrodose app and the experience of the company's therapist, Jeff Hamburg.
Upon projected arrival at CCrest Labs in a few weeks, Red Light's psilocybe Truffles will be produced and tested in accordance with quality control requirements that will hopefully allow the products to be accessible in the emerging legal markets across the globe. These measures include dosage testing, certificate of analysis testing, stability testing and child proof safety bottles.
"We are carefully but aggressively seeking to open up our Netherland's grown truffles to new legal markets for natural psilocybin products. In particular, Red Light is specifically focused on product development targeting areas we believe are most likely to succeed. We don't want to get ahead of ourselves, as we know there may be many hurdles to get homogenized microdosing capsules to customers in emerging markets, but with our excellent partnership with CCrest Laboratories we see a possible path that is very exciting," said Todd Shapiro, CEO and Director of Red Light Holland. "The knowledge gained, continued R&D and product development we plan on creating here is exciting and Red Light will provide updates when our Netherlands' fresh grown Psilocybe Truffles have landed at CCrest Laboratories, in Montreal, Canada via a Health Canada approved psilocybin import permit, which is projected to arrive within the next few weeks," added Shapiro.
"At CCrest Labs, we are thrilled to leverage the expertise of our esteemed scientists to research and develop a high quality potential dosage of psilocybe truffles in a way that preserves their natural integrity. Our collaboration with Red Light, a pioneering partner in this field, allows us to push the boundaries of discovery and make meaningful progress in the psychedelic sector. We are proud to operate in compliance with Health Canada regulations and maintain the highest standards of quality and safety. Together with Red Light, we are committed to advancing this exciting field with caution and care, and we are grateful for the opportunity to contribute a positive impact through disruptive innovation," said Alex Grenier, CEO of Shaman Pharma and President of CCrest Laboratories.
About Shaman Pharma Corp.
Shaman Pharma is a federally registered Canadian corporation with the mission to power outstanding psychedelic life science innovation. Accelerating time-to-market through its portfolio of assets, Shaman launches and consolidates revenue-driven pharma-biotech life sciences ventures focused on supplying psychedelic drugs & novel active ingredients.
About Red Light Holland
Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws.
We seek Safe Harbor.
© 2023 Canjex Publishing Ltd. All rights reserved.